Latest news
Loading news…
DMD Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Seattle, Washington, United States Founded 2016 1-10 employees For Profit
DMD Therapeutics intends to use the funds to move DMD-813 into drug development for the treatment of Duchenne Muscular Dystrophy.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
- Valuation range
- $1M to $10M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- IT spend
- $9M
Company Info
- Founded
- 2016
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- HQ
- Seattle, Washington, United States
- Region
- Greater Seattle Area, West Coast, Western US
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0
- Trend (90d)
- 0
Key People at DMD Therapeutics
President and CEO
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to DMD Therapeutics
Loading news…
FAQs about DMD Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.